A detailed history of Boston Research & Management Inc transactions in Stryker Corp stock. As of the latest transaction made, Boston Research & Management Inc holds 4,354 shares of SYK stock, worth $1.74 Million. This represents 0.37% of its overall portfolio holdings.

Number of Shares
4,354
Previous 4,354 -0.0%
Holding current value
$1.74 Million
Previous $1.48 Million 6.14%
% of portfolio
0.37%
Previous 0.37%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2020

Feb 09, 2021

SELL
$202.01 - $245.04 $1,212 - $1,470
-6 Reduced 0.14%
4,354 $1.07 Million
Q2 2020

Aug 10, 2020

BUY
$144.67 - $207.03 $868 - $1,242
6 Added 0.14%
4,360 $785,000
Q1 2020

May 08, 2020

SELL
$126.5 - $225.1 $22,770 - $40,518
-180 Reduced 3.97%
4,354 $724,000
Q4 2017

Feb 09, 2018

SELL
$143.51 - $159.74 $14,351 - $15,974
-100 Reduced 2.16%
4,534 $702,000
Q3 2017

Nov 09, 2017

BUY
$138.36 - $147.87 $641,160 - $685,229
4,634
4,634 $658,000

Others Institutions Holding SYK

About STRYKER CORP


  • Ticker SYK
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 378,320,992
  • Market Cap $151B
  • Description
  • Stryker Corporation operates as a medical technology company. The company operates through two segments, MedSurg and Neurotechnology, and Orthopaedics and Spine. The Orthopaedics and Spine segment provides implants for use in hip and knee joint replacements, and trauma and extremities surgeries. This segment also offers spinal implant products c...
More about SYK
Track This Portfolio

Track Boston Research & Management Inc Portfolio

Follow Boston Research & Management Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Boston Research & Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Boston Research & Management Inc with notifications on news.